The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cevimeline (trade name Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. It is used in the treatment of dry mouth and especially associated with Sjögren's syndrome.
The global Cevimeline market was valued at US$ 214 million in 2023 and is anticipated to reach US$ 325.3 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Cevimeline is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cevimeline is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cevimeline include Daiichi Sankyo, Novel Laboratories, Rising Pharmaceuticals, West-Ward Pharmaceuticals, Lupin and Sun Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cevimeline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cevimeline.
Report Scope
The Cevimeline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cevimeline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cevimeline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo
Novel Laboratories
Rising Pharmaceuticals
West-Ward Pharmaceuticals
Lupin
Sun Pharmaceutical
Segment by Type
20mg
30mg
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cevimeline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cevimeline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cevimeline (trade name Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. It is used in the treatment of dry mouth and especially associated with Sjögren's syndrome.
The global Cevimeline market was valued at US$ 214 million in 2023 and is anticipated to reach US$ 325.3 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Cevimeline is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cevimeline is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cevimeline include Daiichi Sankyo, Novel Laboratories, Rising Pharmaceuticals, West-Ward Pharmaceuticals, Lupin and Sun Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cevimeline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cevimeline.
Report Scope
The Cevimeline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cevimeline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cevimeline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo
Novel Laboratories
Rising Pharmaceuticals
West-Ward Pharmaceuticals
Lupin
Sun Pharmaceutical
Segment by Type
20mg
30mg
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cevimeline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cevimeline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cevimeline Market Overview
1.1 Product Overview and Scope of Cevimeline
1.2 Cevimeline Segment by Type
1.2.1 Global Cevimeline Market Value Comparison by Type (2024-2030)
1.2.2 20mg
1.2.3 30mg
1.3 Cevimeline Segment by Application
1.3.1 Global Cevimeline Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Cevimeline Market Size Estimates and Forecasts
1.4.1 Global Cevimeline Revenue 2019-2030
1.4.2 Global Cevimeline Sales 2019-2030
1.4.3 Global Cevimeline Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cevimeline Market Competition by Manufacturers
2.1 Global Cevimeline Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cevimeline Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cevimeline Average Price by Manufacturers (2019-2024)
2.4 Global Cevimeline Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cevimeline, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cevimeline, Product Type & Application
2.7 Cevimeline Market Competitive Situation and Trends
2.7.1 Cevimeline Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cevimeline Players Market Share by Revenue
2.7.3 Global Cevimeline Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cevimeline Retrospective Market Scenario by Region
3.1 Global Cevimeline Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cevimeline Global Cevimeline Sales by Region: 2019-2030
3.2.1 Global Cevimeline Sales by Region: 2019-2024
3.2.2 Global Cevimeline Sales by Region: 2025-2030
3.3 Global Cevimeline Global Cevimeline Revenue by Region: 2019-2030
3.3.1 Global Cevimeline Revenue by Region: 2019-2024
3.3.2 Global Cevimeline Revenue by Region: 2025-2030
3.4 North America Cevimeline Market Facts & Figures by Country
3.4.1 North America Cevimeline Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cevimeline Sales by Country (2019-2030)
3.4.3 North America Cevimeline Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cevimeline Market Facts & Figures by Country
3.5.1 Europe Cevimeline Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cevimeline Sales by Country (2019-2030)
3.5.3 Europe Cevimeline Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cevimeline Market Facts & Figures by Country
3.6.1 Asia Pacific Cevimeline Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cevimeline Sales by Country (2019-2030)
3.6.3 Asia Pacific Cevimeline Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cevimeline Market Facts & Figures by Country
3.7.1 Latin America Cevimeline Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cevimeline Sales by Country (2019-2030)
3.7.3 Latin America Cevimeline Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cevimeline Market Facts & Figures by Country
3.8.1 Middle East and Africa Cevimeline Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cevimeline Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cevimeline Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cevimeline Sales by Type (2019-2030)
4.1.1 Global Cevimeline Sales by Type (2019-2024)
4.1.2 Global Cevimeline Sales by Type (2025-2030)
4.1.3 Global Cevimeline Sales Market Share by Type (2019-2030)
4.2 Global Cevimeline Revenue by Type (2019-2030)
4.2.1 Global Cevimeline Revenue by Type (2019-2024)
4.2.2 Global Cevimeline Revenue by Type (2025-2030)
4.2.3 Global Cevimeline Revenue Market Share by Type (2019-2030)
4.3 Global Cevimeline Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cevimeline Sales by Application (2019-2030)
5.1.1 Global Cevimeline Sales by Application (2019-2024)
5.1.2 Global Cevimeline Sales by Application (2025-2030)
5.1.3 Global Cevimeline Sales Market Share by Application (2019-2030)
5.2 Global Cevimeline Revenue by Application (2019-2030)
5.2.1 Global Cevimeline Revenue by Application (2019-2024)
5.2.2 Global Cevimeline Revenue by Application (2025-2030)
5.2.3 Global Cevimeline Revenue Market Share by Application (2019-2030)
5.3 Global Cevimeline Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Corporation Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Cevimeline Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Daiichi Sankyo Cevimeline Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Novel Laboratories
6.2.1 Novel Laboratories Corporation Information
6.2.2 Novel Laboratories Description and Business Overview
6.2.3 Novel Laboratories Cevimeline Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novel Laboratories Cevimeline Product Portfolio
6.2.5 Novel Laboratories Recent Developments/Updates
6.3 Rising Pharmaceuticals
6.3.1 Rising Pharmaceuticals Corporation Information
6.3.2 Rising Pharmaceuticals Description and Business Overview
6.3.3 Rising Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Rising Pharmaceuticals Cevimeline Product Portfolio
6.3.5 Rising Pharmaceuticals Recent Developments/Updates
6.4 West-Ward Pharmaceuticals
6.4.1 West-Ward Pharmaceuticals Corporation Information
6.4.2 West-Ward Pharmaceuticals Description and Business Overview
6.4.3 West-Ward Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2019-2024)
6.4.4 West-Ward Pharmaceuticals Cevimeline Product Portfolio
6.4.5 West-Ward Pharmaceuticals Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Corporation Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin Cevimeline Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lupin Cevimeline Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Cevimeline Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Cevimeline Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cevimeline Industry Chain Analysis
7.2 Cevimeline Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cevimeline Production Mode & Process
7.4 Cevimeline Sales and Marketing
7.4.1 Cevimeline Sales Channels
7.4.2 Cevimeline Distributors
7.5 Cevimeline Customers
8 Cevimeline Market Dynamics
8.1 Cevimeline Industry Trends
8.2 Cevimeline Market Drivers
8.3 Cevimeline Market Challenges
8.4 Cevimeline Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
